Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-09-05

Clinical Trial Update: Effects of Spironolactone in Dialysis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating the effects of spironolactone in patients undergoing dialysis for renal failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Spironolactone (spironolactone)

Snippet

Sponsor: UPECLIN HC FM Botucatu Unesp | Conditions: Renal Failure | Phase 4 | Status: UNKNOWN